Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Neuromuscular Disease
1.2.3 Genetic Disease
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Therapy Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Drugs Market Perspective (2018-2034)
2.2 Gene Therapy Drugs Growth Trends by Region
2.2.1 Global Gene Therapy Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Gene Therapy Drugs Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy Drugs Forecasted Market Size by Region (2024-2034)
2.3 Gene Therapy Drugs Market Dynamics
2.3.1 Gene Therapy Drugs Industry Trends
2.3.2 Gene Therapy Drugs Market Drivers
2.3.3 Gene Therapy Drugs Market Challenges
2.3.4 Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Drugs Players by Revenue
3.1.1 Global Top Gene Therapy Drugs Players by Revenue (2018-2023)
3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Drugs Revenue
3.4 Global Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2024
3.5 Gene Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Gene Therapy Drugs Product Solution and Service
3.7 Date of Enter into Gene Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Drugs Breakdown Data by Type
4.1 Global Gene Therapy Drugs Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2024-2034)
5 Gene Therapy Drugs Breakdown Data by Application
5.1 Global Gene Therapy Drugs Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Gene Therapy Drugs Market Size (2018-2034)
6.2 North America Gene Therapy Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Gene Therapy Drugs Market Size by Country (2018-2023)
6.4 North America Gene Therapy Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy Drugs Market Size (2018-2034)
7.2 Europe Gene Therapy Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Gene Therapy Drugs Market Size by Country (2018-2023)
7.4 Europe Gene Therapy Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Drugs Market Size (2018-2034)
8.2 Asia-Pacific Gene Therapy Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Gene Therapy Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Therapy Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy Drugs Market Size (2018-2034)
9.2 Latin America Gene Therapy Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Gene Therapy Drugs Market Size by Country (2018-2023)
9.4 Latin America Gene Therapy Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Drugs Market Size (2018-2034)
10.2 Middle East & Africa Gene Therapy Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Gene Therapy Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Therapy Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 F. Hoffmann-La Roche AG Company Detail
11.1.2 F. Hoffmann-La Roche AG Business Overview
11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction
11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2018-2023)
11.1.5 F. Hoffmann-La Roche AG Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Detail
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Gene Therapy Drugs Introduction
11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2018-2023)
11.2.5 Novartis International AG Recent Development
11.3 Gilead Sciences, Inc.
11.3.1 Gilead Sciences, Inc. Company Detail
11.3.2 Gilead Sciences, Inc. Business Overview
11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction
11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2018-2023)
11.3.5 Gilead Sciences, Inc. Recent Development
11.4 Ultragenyx Pharmaceutical，Inc.
11.4.1 Ultragenyx Pharmaceutical，Inc. Company Detail
11.4.2 Ultragenyx Pharmaceutical，Inc. Business Overview
11.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Introduction
11.4.4 Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2018-2023)
11.4.5 Ultragenyx Pharmaceutical，Inc. Recent Development
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Detail
11.5.2 Applied Genetic Technologies Corp Business Overview
11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction
11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2018-2023)
11.5.5 Applied Genetic Technologies Corp Recent Development
11.6 Audentes Therapeutics
11.6.1 Audentes Therapeutics Company Detail
11.6.2 Audentes Therapeutics Business Overview
11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction
11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023)
11.6.5 Audentes Therapeutics Recent Development
11.7 BioMarin Pharmaceutical
11.7.1 BioMarin Pharmaceutical Company Detail
11.7.2 BioMarin Pharmaceutical Business Overview
11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction
11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2018-2023)
11.7.5 BioMarin Pharmaceutical Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Detail
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Gene Therapy Drugs Introduction
11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2018-2023)
11.8.5 Bluebird Bio Recent Development
11.9 Nightstar Therapeutics
11.9.1 Nightstar Therapeutics Company Detail
11.9.2 Nightstar Therapeutics Business Overview
11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction
11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023)
11.9.5 Nightstar Therapeutics Recent Development
11.10 Sangamo Therapeutics
11.10.1 Sangamo Therapeutics Company Detail
11.10.2 Sangamo Therapeutics Business Overview
11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction
11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023)
11.10.5 Sangamo Therapeutics Recent Development
11.11 Spark Therapeutics
11.11.1 Spark Therapeutics Company Detail
11.11.2 Spark Therapeutics Business Overview
11.11.3 Spark Therapeutics Gene Therapy Drugs Introduction
11.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023)
11.11.5 Spark Therapeutics Recent Development
11.12 uniQure
11.12.1 uniQure Company Detail
11.12.2 uniQure Business Overview
11.12.3 uniQure Gene Therapy Drugs Introduction
11.12.4 uniQure Revenue in Gene Therapy Drugs Business (2018-2023)
11.12.5 uniQure Recent Development
11.13 VBL Therapeutics
11.13.1 VBL Therapeutics Company Detail
11.13.2 VBL Therapeutics Business Overview
11.13.3 VBL Therapeutics Gene Therapy Drugs Introduction
11.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023)
11.13.5 VBL Therapeutics Recent Development
11.14 Voyager Therapeutics
11.14.1 Voyager Therapeutics Company Detail
11.14.2 Voyager Therapeutics Business Overview
11.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction
11.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023)
11.14.5 Voyager Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Neuromuscular Disease
Table 3. Key Players of Genetic Disease
Table 4. Key Players of Other
Table 5. Global Gene Therapy Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Gene Therapy Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Gene Therapy Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gene Therapy Drugs Market Share by Region (2018-2023)
Table 9. Global Gene Therapy Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Gene Therapy Drugs Market Share by Region (2024-2034)
Table 11. Gene Therapy Drugs Market Trends
Table 12. Gene Therapy Drugs Market Drivers
Table 13. Gene Therapy Drugs Market Challenges
Table 14. Gene Therapy Drugs Market Restraints
Table 15. Global Gene Therapy Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gene Therapy Drugs Market Share by Players (2018-2023)
Table 17. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2024)
Table 18. Ranking of Global Top Gene Therapy Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Gene Therapy Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Therapy Drugs Product Solution and Service
Table 22. Date of Enter into Gene Therapy Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gene Therapy Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Gene Therapy Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Gene Therapy Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gene Therapy Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Gene Therapy Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Gene Therapy Drugs Revenue Market Share by Application (2024-2034)
Table 32. North America Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Gene Therapy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Gene Therapy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Gene Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Gene Therapy Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Gene Therapy Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Gene Therapy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Gene Therapy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. F. Hoffmann-La Roche AG Company Detail
Table 48. F. Hoffmann-La Roche AG Business Overview
Table 49. F. Hoffmann-La Roche AG Gene Therapy Drugs Product
Table 50. F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 51. F. Hoffmann-La Roche AG Recent Development
Table 52. Novartis International AG Company Detail
Table 53. Novartis International AG Business Overview
Table 54. Novartis International AG Gene Therapy Drugs Product
Table 55. Novartis International AG Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 56. Novartis International AG Recent Development
Table 57. Gilead Sciences, Inc. Company Detail
Table 58. Gilead Sciences, Inc. Business Overview
Table 59. Gilead Sciences, Inc. Gene Therapy Drugs Product
Table 60. Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 61. Gilead Sciences, Inc. Recent Development
Table 62. Ultragenyx Pharmaceutical，Inc. Company Detail
Table 63. Ultragenyx Pharmaceutical，Inc. Business Overview
Table 64. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product
Table 65. Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 66. Ultragenyx Pharmaceutical，Inc. Recent Development
Table 67. Applied Genetic Technologies Corp Company Detail
Table 68. Applied Genetic Technologies Corp Business Overview
Table 69. Applied Genetic Technologies Corp Gene Therapy Drugs Product
Table 70. Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 71. Applied Genetic Technologies Corp Recent Development
Table 72. Audentes Therapeutics Company Detail
Table 73. Audentes Therapeutics Business Overview
Table 74. Audentes Therapeutics Gene Therapy Drugs Product
Table 75. Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 76. Audentes Therapeutics Recent Development
Table 77. BioMarin Pharmaceutical Company Detail
Table 78. BioMarin Pharmaceutical Business Overview
Table 79. BioMarin Pharmaceutical Gene Therapy Drugs Product
Table 80. BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 81. BioMarin Pharmaceutical Recent Development
Table 82. Bluebird Bio Company Detail
Table 83. Bluebird Bio Business Overview
Table 84. Bluebird Bio Gene Therapy Drugs Product
Table 85. Bluebird Bio Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 86. Bluebird Bio Recent Development
Table 87. Nightstar Therapeutics Company Detail
Table 88. Nightstar Therapeutics Business Overview
Table 89. Nightstar Therapeutics Gene Therapy Drugs Product
Table 90. Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 91. Nightstar Therapeutics Recent Development
Table 92. Sangamo Therapeutics Company Detail
Table 93. Sangamo Therapeutics Business Overview
Table 94. Sangamo Therapeutics Gene Therapy Drugs Product
Table 95. Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 96. Sangamo Therapeutics Recent Development
Table 97. Spark Therapeutics Company Detail
Table 98. Spark Therapeutics Business Overview
Table 99. Spark Therapeutics Gene Therapy Drugs Product
Table 100. Spark Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 101. Spark Therapeutics Recent Development
Table 102. uniQure Company Detail
Table 103. uniQure Business Overview
Table 104. uniQure Gene Therapy Drugs Product
Table 105. uniQure Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 106. uniQure Recent Development
Table 107. VBL Therapeutics Company Detail
Table 108. VBL Therapeutics Business Overview
Table 109. VBL Therapeutics Gene Therapy Drugs Product
Table 110. VBL Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 111. VBL Therapeutics Recent Development
Table 112. Voyager Therapeutics Company Detail
Table 113. Voyager Therapeutics Business Overview
Table 114. Voyager Therapeutics Gene Therapy Drugs Product
Table 115. Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2018-2023) & (US$ Million)
Table 116. Voyager Therapeutics Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Drugs Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Gene Therapy Drugs Market Share by Type: 2024 VS 2034
Figure 3. Neuromuscular Disease Features
Figure 4. Genetic Disease Features
Figure 5. Other Features
Figure 6. Global Gene Therapy Drugs Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global Gene Therapy Drugs Market Share by Application: 2024 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Gene Therapy Drugs Report Years Considered
Figure 11. Global Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Gene Therapy Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Gene Therapy Drugs Market Share by Region: 2024 VS 2034
Figure 14. Global Gene Therapy Drugs Market Share by Players in 2024
Figure 15. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy Drugs Revenue in 2024
Figure 17. North America Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Gene Therapy Drugs Market Share by Country (2018-2034)
Figure 19. United States Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Gene Therapy Drugs Market Share by Country (2018-2034)
Figure 23. Germany Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy Drugs Market Share by Region (2018-2034)
Figure 31. China Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Gene Therapy Drugs Market Share by Country (2018-2034)
Figure 39. Mexico Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy Drugs Market Share by Country (2018-2034)
Figure 43. Turkey Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. F. Hoffmann-La Roche AG Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 46. Novartis International AG Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 47. Gilead Sciences, Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 48. Ultragenyx Pharmaceutical，Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 49. Applied Genetic Technologies Corp Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 50. Audentes Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 51. BioMarin Pharmaceutical Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 52. Bluebird Bio Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 53. Nightstar Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 54. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 55. Spark Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 56. uniQure Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 57. VBL Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 58. Voyager Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed